Rankings
▼
Calendar
ESPR FY 2017 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$519M
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$258,000
Operating Income
-$169M
Net Income
-$167M
EPS (Diluted)
$-6.98
Cash Flow
Operating Cash Flow
-$131M
Free Cash Flow
-$131M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$278M
Total Liabilities
$33M
Stockholders' Equity
$245M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$258,000
-$252,000
-2.4%
Operating Income
-$169M
-$76M
-121.9%
Net Income
-$167M
-$75M
-122.7%
← Q4 2016
All Quarters
Q1 2017 →